Skip to Content
Merck
CN

Orkambi® and amplifier co-therapy improves function from a rare

EMBO molecular medicine (2017-07-02)
Steven V Molinski, Saumel Ahmadi, Wan Ip, Hong Ouyang, Adriana Villella, John P Miller, Po-Shun Lee, Kethika Kulleperuma, Kai Du, Michelle Di Paola, Paul Dw Eckford, Onofrio Laselva, Ling Jun Huan, Leigh Wellhauser, Ellen Li, Peter N Ray, Régis Pomès, Theo J Moraes, Tanja Gonska, Felix Ratjen, Christine E Bear
ABSTRACT

The combination therapy of lumacaftor and ivacaftor (Orkambi

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Forskolin, from Coleus forskohlii, ≥98% (HPLC), powder